Black Maple Capital Management’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Black Maple Capital Management’s Portfolio OPNT Stock Details OPNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-48,548	Closed	-$985K	–	106
2022 Q4	$985K	Buy	+48,548	New	+$744K	1.45%	15

Black Maple Capital Management's OPNT Position: Q1 2023 in Review

Black Maple Capital Management sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q1 2023, closing a stake of 48,548 shares — an estimated $985K sold.

Black Maple Capital Management first reported a position in OPNT in Q4 2022 and held it in 1 quarter. The position peaked at $985K in Q4 2022. 0 funds tracked by Wall St. Rank hold OPNT as of Q1 2023.

Black Maple Capital Management reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Black Maple Capital Management sold 48,548 Opiant Pharmaceuticals, Inc. Common Stock shares in Q1 2023, an estimated $985K.
Black Maple Capital Management first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
Black Maple Capital Management's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $985K in Q4 2022.
0 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q1 2023.

Based on Black Maple Capital Management's 13F filing for Q1 2023, filed 15 May 2023.